CPI-006
Non-Small Cell Lung Cancer, Head & Neck Squamous Cell Carcinoma
Phase 1/2Active (trials in China)
Key Facts
Indication
Non-Small Cell Lung Cancer, Head & Neck Squamous Cell Carcinoma
Phase
Phase 1/2
Status
Active (trials in China)
Company
About Angel Pharmaceuticals
A Chinese biotech developing first-in-class and best-in-class oncology/autoimmune drugs through global partnerships and internal R&D.
View full company profile